HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 295/5/R1599    most recent 00020.2008v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Johnson, S. M. Articles by Wiegel, L. M. Search for Related Content PubMed PubMed Citation Articles by Johnson, S. M. Articles by Wiegel, L. M.

EXERCISE AND RESPIRATORY PHYSIOLOGY

Inhibitory and excitatory effects of µ-, -, and -opioid receptor activation on breathing in awake turtles, Trachemys scripta

Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin

Submitted 13 August 2008 ; accepted in final form 3 September 2008

For ectothermic vertebrates, such as reptiles, the effects of opioid receptor subtype activation on breathing are poorly understood. On the basis of previous studies on mammals and lampreys, we hypothesized that µ- and -opioid receptor (MOR and DOR, respectively) activation would cause respiratory depression, whereas -opioid receptor (KOR) activation would have no effect. To address this question, we measured respiration in awake, freely swimming adult red-eared slider turtles (Trachemys scripta) before and after injection with agonists for specific opioid receptors. Injection of the MOR agonist [D-Ala²,N-Me-Phe⁴,Gly⁵-ol]-enkephalin acetate salt (DAMGO, 1.5 or 6.5 mg/kg) decreased ventilation (E) by 72 ± 9% and 95 ± 3%, respectively, 4.0 h after injection as a result of decreased breathing frequency and no change in tidal volume (VT). DOR agonists, such as [D-Pen^2,5]-enkephalin hydrate (DPDPE, 5.0 mg/kg) and [D-Ala²,D-Leu⁵]-enkephalin acetate salt (DADLE, 6.3 mg/kg), decreased E by 44 ± 10% and 89 ± 4%, respectively, 4.0 h after injection as a result of decreased breathing frequency and no change in VT. DADLE also increased breath duration by a maximum of 25 ± 9% at 6.0 h after injection. The KOR agonist U-50488 (6.2 mg/kg) increased VT by a maximum of 52 ± 30% at 5.0 h after injection, with variable nonsignificant changes in E and breathing frequency. Naloxone injections (0.25–0.5 mg/kg) 1.0 h before opioid agonist injections blocked all DAMGO-dependent effects, DPDPE-dependent frequency depression, and DADLE-dependent breath duration augmentation for 2.0 h after agonist injections. These results show that MOR and DOR activation causes respiratory depression as a result of decreased breathing frequency, whereas VT is increased after KOR activation.

reptile; respiration; chelonian